Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Sharif Kullab"'
Autor:
Humaid O. Al-Shamsi, Ahmed Alwbari, Fathi Azribi, Francois Calaud, Sanjay Thuruthel, Syed Hammad Hassan Tirmazy, Sharif Kullab, Sonia Ostomane, Omalkhair Abulkhair
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BReast CAncer (BRCA)1 and BRCA2 gene pathogenic variants account for most hereditary breast cancers (BC). Identification of BRCA mutations can significantly influence both prognosis and treatment outcomes. Furthermore, it enables the identification o
Externí odkaz:
https://doaj.org/article/70242e37e79148269158ea197f5b9c32
Autor:
Kosmas V. Kepesidis, Masa Bozic-Iven, Marinus Huber, Nashwa Abdel-Aziz, Sharif Kullab, Ahmed Abdelwarith, Abdulrahman Al Diab, Mohammed Al Ghamdi, Muath Abu Hilal, Mohun R. K. Bahadoor, Abhishake Sharma, Farida Dabouz, Maria Arafah, Abdallah M. Azzeer, Ferenc Krausz, Khalid Alsaleh, Mihaela Zigman, Jean-Marc Nabholtz
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Breast cancer screening is currently predominantly based on mammography, tainted with the occurrence of both false positivity and false negativity, urging for innovative strategies, as effective detection of early-stage breast can
Externí odkaz:
https://doaj.org/article/86f63562cf714b39822630151a6d4980
Autor:
Khalid AlSaleh, Heba Al Zahwahry, Adda Bounedjar, Mohammed Oukkal, Ahmed Saadeddine, Hassen Mahfouf, Kamel Bouzid, Assia Bensalem, Taha Filali, Hikmat Abdel-Razeq, Blaha Larbaoui, Alaa Kandil, Omalkhair Abulkhair, Meteb Al Foheidi, Hassan Errihani, Marwan Ghosn, Nashwa Abdel-Aziz, Maria Arafah, Hamouda Boussen, Farida Dabouz, Haleem Rasool, Mohun Bahadoor, Jihen Ayari, Sharif Kullab, Jean-Marc Nabholtz
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 811-819 (2021)
PURPOSELuminal, human epidermal growth factor receptor 2–negative breast cancer represents the most common subtype of breast malignancies. Neoadjuvant strategies of operable breast cancer are mostly based on chemotherapy, whereas it is not complete
Externí odkaz:
https://doaj.org/article/2c1a61b7a7c6405ea5cfcbca34eb0534
Autor:
Nicolas Kerckhove, Marie Selvy, Céline Lambert, Coralie Gonneau, Gabrielle Feydel, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouché, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Jérôme Busserolles, Sophie Trévis, Vincent Pinon, Denis Pezet, David Balayssac
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in color
Externí odkaz:
https://doaj.org/article/2b597ee8a3434985a82d29f25ae2a813
Autor:
Erdoğan Nohuz, Sharif Kullab, Albane Ledoux - Pilon, Cécile Moluçon - Chabrot, Maël Albaut, Luisa De Simone, Xavier Durando
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 3, Pp 259-260 (2016)
Externí odkaz:
https://doaj.org/article/4ea063cadef042a09401da3a637fcd22
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4207e7b0754238cc4ed0c5b2b6ff1843
https://doi.org/10.7759/cureus.22686
https://doi.org/10.7759/cureus.22686
Autor:
Mohammed Al Ghamdi, Maria Arafah, Kosmas V. Kepesidis, Abdulrahman Al Diab, Mihaela Zigman, Abdallah M. Azzeer, Jean-Marc Nabholtz, Abhishake Sharma, Masa Bozic-Iven, Marinus Huber, Ahmed Abdelwarith, Mohun Bahadoor, Sharif Kullab, Nashwa Abdel-Aziz, Ferenc Krausz, Khalid Alsaleh, Farida Dabouz, Muath Abu Hilal
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background Breast cancer screening is currently predominantly based on mammography, tainted with the occurrence of both false positivity and false negativity, urging for innovative strategies, as effective detection of early-stage breast cancer bears
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba32c1d7428b73b0f2dddc0a9a11ddb
https://pubmed.ncbi.nlm.nih.gov/34856945
https://pubmed.ncbi.nlm.nih.gov/34856945
Autor:
J. Ayari, Hassan Errihani, Ahmed Saadeddine, Taha Filali, Khalid Alsaleh, Haleem Rasool, Hamouda Boussen, Meteb Al Foheidi, Farida Dabouz, Blaha Larbaoui, Adda Bounedjar, Hassen Mahfouf, Assia Bensalem, Marwan Ghosn, Mohammed Oukkal, Maria Arafah, K. Bouzid, Hikmat Abdel-Razeq, Alaa Kandil, Mohun Bahadoor, Nashwa Abdel-Aziz, Omalkhair Abulkhair, Jean-Marc Nabholtz, Heba Al Zahwahry, Sharif Kullab
Publikováno v:
JCO Global Oncology
PURPOSE Luminal, human epidermal growth factor receptor 2–negative breast cancer represents the most common subtype of breast malignancies. Neoadjuvant strategies of operable breast cancer are mostly based on chemotherapy, whereas it is not complet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e01af8abc0b805456849b1e2e65c82
https://pubmed.ncbi.nlm.nih.gov/34086481
https://pubmed.ncbi.nlm.nih.gov/34086481
Autor:
Vincent Pinon, Caroline Pétorin, Coralie Gonneau, Florent Genty, Valerie Lebrun-Ly, Cécile Leyronnas, Denis Pezet, Kheir Eddine Benmammar, Marie Selvy, Mohamed Ramdani, Vincent Bourgeois, Frédéric Thuillier, Sharif Kullab, Brigitte Monange, Mohamed Hebbar, Sergey Melnikov, Olivier Bouché, Thibault Mazard, Florian Slimano, Floriane Huet-Penz, Sophie Trevis, David Tavan, Denis Péré-Vergé, David Balayssac, Ahmed Bedjaoui, Gabrielle Feydel, Bruno Pereira, Agnès Vimal-Baguet, Jérôme Busserolles, Nicolas Kerckhove
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, MDPI, 2020, 9 (8), pp.2400. ⟨10.3390/jcm9082400⟩
Journal of Clinical Medicine, 2020, 9 (8), pp.2400. ⟨10.3390/jcm9082400⟩
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2400, p 2400 (2020)
Journal of Clinical Medicine, MDPI, 2020, 9 (8), pp.2400. ⟨10.3390/jcm9082400⟩
Journal of Clinical Medicine, 2020, 9 (8), pp.2400. ⟨10.3390/jcm9082400⟩
Volume 9
Issue 8
Journal of Clinical Medicine, Vol 9, Iss 2400, p 2400 (2020)
(1) Background: Oxaliplatin is among the most neurotoxic anticancer drugs. Little data are available on the long-term prevalence and consequences of chemotherapy-induced peripheral neuropathy (CIPN), even though the third largest population of cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1bb2b834682c2eb79c9679c31827b55
https://hal.uca.fr/hal-02997588/document
https://hal.uca.fr/hal-02997588/document
Autor:
N. Chalabi, K.E. Benmammar, V. Servent, Sharif Kullab, Xavier Durando, I. van Praagh, Anne Cayre, Fabrice Kwiatkowski, Y-J Bignon, Nina Radosevic-Robin, M.M. Dauplat, Catherine Abrial, J.P. Jacquin, J-M Nabholtz, Frédérique Penault-Llorca, Ph. Chollet, Marie-Ange Mouret-Reynier, M.R.K. Bahadoor
Publikováno v:
International Journal of Cancer. 138:2274-2280
Systemic therapy for triple negative breast cancer (TNBC) is mostly based upon chemotherapy. Epithelial Growth Factor Receptor (EGFR) is overexpressed in around 50% of TNBC and may play a role in its pathogenesis. Consequently, we performed a multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::118b2865724f80ed889ac2438b8de110
https://doi.org/10.1002/ijc.29952
https://doi.org/10.1002/ijc.29952